Li Zhu

3PUBLICATIONS
24CO-AUTHORS
Molecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 13, 2024
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies.

Jason J Luke, Karen Gelmon, Lillian L Siu

|Sep 03, 2024
Exposure-Response-Based Multiattribute Clinical Utility Score Framework to Facilitate Optimal Dose Selection for Oncology Drugs.

Yiming Cheng, Shuyu Chu, Jie Pu

|Mar 29, 2018
Population Pharmacokinetic Analysis of Asunaprevir in Subjects with Hepatitis C Virus Infection.

Li Zhu, Hanbin Li, Phyllis Chan

Pageof 1